Clinical Trial Update: Neoadjuvant Zoledronate and Atorvastatin in Triple Negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating neoadjuvant zoledronate and atorvastatin in triple negative breast cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Zoledronate (zoledronic acid)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Triple Negative Breast Cancer | Phase 2 | Status: COMPLETED